Valuation dashboard for Precision Optics Corporation, Inc. (POCI) with P/E N/A, P/B 1.62, EV/EBITDA -9.26 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers.
Analysis Summary
Precision Optics Corporation, Inc. reported revenue of $19.1M in the most recent fiscal year, growing at a 5-year CAGR of 14.0%.
Trailing-twelve-month margins: gross margin 13.8%, operating margin -16.4%, net margin -17.0%.
At the current price of $4.17, POCI has negative trailing earnings (P/E not meaningful) and an ROE of -37.47%. Market capitalisation stands at $46M.
Balance sheet quality for POCI: current ratio of 1.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.62 |
| EV / EBITDA | -9.26 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-15.83 |
| vs Current Price | -479.6% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| POCI | Precision Optics Corporation, Inc. | $46M | 1.62 | -37.5% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $4.17 |
| Market Cap | $46M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -37.47% |
| Return on Invested Capital | -19.51% |
| Return on Assets | -14.63% |
| Gross Margin | 13.85% |
| Operating Margin | -16.44% |
| Net Margin | -17.03% |
Related companies: APUS · HBIO · IGC · MIRA · MLSS · MODD · MYO
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of POCI: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks